ChemPartner(SZ:300149) Sou Hu Cai Jing·2025-12-15 02:15Core Viewpoint - Recently, Ruizhi Pharmaceutical (SZ300149) announced the resignation of its Secretary of the Board, Gao Yingying, due to job adjustments, which raises questions about management stability and continuity within the company [1][3]. Group 1: Management Changes - Gao Yingying, born in 1994, submitted her resignation just 11 days after taking office as Secretary of the Board, which is a notably short tenure [3]. - Gao was originally appointed to serve until the end of the sixth Board term and did not hold any shares in the company at the time of her resignation [3]. - The company has appointed the Chairman and CEO, Woosweelian, to temporarily assume the duties of the Secretary of the Board while a new appointment is made [3]. Group 2: Background of Gao Yingying - Gao Yingying holds a bachelor's degree and is currently pursuing a Master's in Business Administration at Shanghai Normal University [3]. - Prior to joining Ruizhi Pharmaceutical, she worked in various roles at local broadcasting stations from 2016 to 2022, including planning, hosting, directing, and editing [3]. - In November 2022, she transitioned to Zhongshan Anxin New Retail Co., Ltd. as Promotion Director before officially becoming the Secretary of the Board at Ruizhi Pharmaceutical in December 2025 [3]. Group 3: Company Overview - Ruizhi Pharmaceutical is a provider of integrated research and production services for biopharmaceuticals and chemical drugs, aiming to offer comprehensive lifecycle solutions from early discovery to large-scale production for global pharmaceutical companies, biotechnology firms, and research institutions [3].